CHLORTHALIDONE PHARMACODYNAMICS IN BEAGLE DOGS

被引：2

作者：

MACGREGOR, TR

KEIRNS, JJ

FARINA, PR

MATZEK, KM

HORHOTA, ST

ESBER, HJ

机构：

[1] BOEHRINGER INGELHEIM PHARMACEUT INC,DEPT PHARMACEUT,RIDGEFIELD,CT 06877

[2] EG & G MASON RES INST,WORCESTER,MA 01608

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1985年 / 74卷 / 08期

关键词：

D O I：

10.1002/jps.2600740810

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：851 / 856

页数：6

共 14 条

[1] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].

BOXENBAU.HG ;

RIEGELMA.S ;

ELASHOFF, RM .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148

[2] BINDING OF CHLORTHALIDONE (HYGROTONR) TO BLOOD COMPONENTS IN MAN [J].

DIETERLE, W ;

WAGNER, J ;

FAIGLE, JW .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 10 (01) :37-42

[3] DIFFERENTIAL POTENTIOMETRIC METHOD FOR DETERMINING DISSOCIATION-CONSTANTS OF VERY SLIGHTLY WATER-SOLUBLE DRUGS APPLIED TO THE SULFONAMIDE DIURETIC CHLORTHALIDONE [J].

FLEUREN, HLJ ;

GINNEKEN, CAMV ;

ROSSUM, JMV .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1056-1058

[4] NONLINEAR RELATIONSHIP BETWEEN PLASMA AND RED BLOOD-CELL PHARMACOKINITICS OF CHLORTHALIDONE IN MAN [J].

FLEUREN, HLJ ;

VANROSSUM, JM .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (04) :359-375

[5]

HEINZEL G, 1982, PHARMACOKINETICS DRU, P207

[6] NEW METHOD FOR CALCULATING INTRINSIC ABSORPTION RATE OF DRUGS [J].

LOO, JCK ;

RIEGELMA.S .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (06) :918-&

[7] ANALYSIS OF CHLORTHALIDONE IN BIOLOGICAL-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY USING A RAPID COLUMN CLEANUP PROCEDURE [J].

MACGREGOR, TR ;

FARINA, PR ;

HAGOPIAN, M ;

HAY, N ;

ESBER, HJ ;

KEIRNS, JJ .

THERAPEUTIC DRUG MONITORING, 1984, 6 (01) :83-90

[8]

MACGREGOR TR, 1982, ABSTRACTS ACADEMY PH

[9]

MATERSON BJ, 1978, CLIN PHARMACOL THER, V24, P192

[10] THE APPLICATION OF STATISTICAL MOMENT THEORY TO THE EVALUATION OF INVIVO DISSOLUTION TIME AND ABSORPTION TIME [J].

RIEGELMAN, S ;

COLLIER, P .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (05) :509-534

← 1 2 →